Safety of Neoadjuvant Bevacizumab plus Pemetrexed and Carboplatin in Patients with IIIa Lung Adenocarcinoma
Background and objective Bevacizumab has showed its efficacy in advanced non-squamous lung cancer. The aim of this study is to assess the safety of bevacizumab plus pemetrexed and carboplatin neoadjuvant chemotherapy in patients with lung adenocarcinoma. Methods 25 patients with IIIa lung adenocarci...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Chinês |
| 出版: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2015-06-01
|
| 叢編: | Chinese Journal of Lung Cancer |
| 主題: | |
| 在線閱讀: | http://dx.doi.org/10.3779/j.issn.1009-3419.2015.06.06 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|